Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
|
Mid-range Performer
2646.4000
19.90
(
0.76
%)
NSE
Jul 14, 2025
15:31 PM
Volume:
446.2K
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
04 Nov 2020
2646.40
0.76%
Ajanta Pharma (BUY): Exceptional Q2 beat; H2 momentum to moderate
Buy:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1920
Target
BOB Capital Markets Ltd.
Ajanta Pharma (AJP) posted Q2 revenue/EBITDA growth of 11%/54% YoY to Rs 7.2bn/Rs 2.7bn.
Ajanta Pharma Ltd. is trading
below its 150 day SMA
of 2671.4
More from Ajanta Pharma Ltd.
Recommended
IPO spree continues with Anthem and two SME issues opening this week
|
14 Jul 2025, 04:42PM
Market closes lower, Ahluwalia Contracts bags a Rs 2,089 crore order from DLF
Trendlyne Marketwatch |
14 Jul 2025, 03:56PM
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017